331 related articles for article (PubMed ID: 24256623)
1. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.
Pawloski LC; Queenan AM; Cassiday PK; Lynch AS; Harrison MJ; Shang W; Williams MM; Bowden KE; Burgos-Rivera B; Qin X; Messonnier N; Tondella ML
Clin Vaccine Immunol; 2014 Feb; 21(2):119-25. PubMed ID: 24256623
[TBL] [Abstract][Full Text] [Related]
2. Clinical Manifestations and Molecular Characterization of Pertactin-Deficient and Pertactin-Producing Bordetella pertussis in Children, Philadelphia 2007-2014.
Vodzak J; Queenan AM; Souder E; Evangelista AT; Long SS
Clin Infect Dis; 2017 Jan; 64(1):60-66. PubMed ID: 27624959
[TBL] [Abstract][Full Text] [Related]
3. Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012.
Zeddeman A; van Gent M; Heuvelman CJ; van der Heide HG; Bart MJ; Advani A; Hallander HO; Wirsing von Konig CH; Riffelman M; Storsaeter J; Vestrheim DF; Dalby T; Krogfelt KA; Fry NK; Barkoff AM; Mertsola J; He Q; Mooi F
Euro Surveill; 2014 Aug; 19(33):. PubMed ID: 25166348
[TBL] [Abstract][Full Text] [Related]
4. Pertactin-negative Bordetella pertussis strains in Canada: characterization of a dozen isolates based on a survey of 224 samples collected in different parts of the country over the last 20 years.
Tsang RS; Shuel M; Jamieson FB; Drews S; Hoang L; Horsman G; Lefebvre B; Desai S; St-Laurent M
Int J Infect Dis; 2014 Nov; 28():65-9. PubMed ID: 25244999
[TBL] [Abstract][Full Text] [Related]
5. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.
Martin SW; Pawloski L; Williams M; Weening K; DeBolt C; Qin X; Reynolds L; Kenyon C; Giambrone G; Kudish K; Miller L; Selvage D; Lee A; Skoff TH; Kamiya H; Cassiday PK; Tondella ML; Clark TA
Clin Infect Dis; 2015 Jan; 60(2):223-7. PubMed ID: 25301209
[TBL] [Abstract][Full Text] [Related]
6. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
[TBL] [Abstract][Full Text] [Related]
7. Rare Detection of Bordetella pertussis Pertactin-Deficient Strains in Argentina.
Carriquiriborde F; Regidor V; Aispuro PM; Magali G; Bartel E; Bottero D; Hozbor D
Emerg Infect Dis; 2019 Nov; 25(11):2048-2054. PubMed ID: 31625838
[TBL] [Abstract][Full Text] [Related]
8. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.
Lam C; Octavia S; Ricafort L; Sintchenko V; Gilbert GL; Wood N; McIntyre P; Marshall H; Guiso N; Keil AD; Lawrence A; Robson J; Hogg G; Lan R
Emerg Infect Dis; 2014 Apr; 20(4):626-33. PubMed ID: 24655754
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan.
Otsuka N; Han HJ; Toyoizumi-Ajisaka H; Nakamura Y; Arakawa Y; Shibayama K; Kamachi K
PLoS One; 2012; 7(2):e31985. PubMed ID: 22348138
[TBL] [Abstract][Full Text] [Related]
10. Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination.
Polak M; Zasada AA; Mosiej E; Krysztopa-Grzybowska K; Witkowski L; Rzeczkowska M; Piekarska K; Lutyńska A
Microbes Infect; 2019; 21(3-4):170-175. PubMed ID: 30580013
[TBL] [Abstract][Full Text] [Related]
11. The evolving nature of
Tsang RSW; Shuel M; Cronin K; Deng S; Whyte K; Marchand-Austin A; Ma J; Bolotin S; Crowcroft N; Schwartz K; Van Domselaar G; Graham M; Jamieson FB
Can J Microbiol; 2019 Nov; 65(11):823-830. PubMed ID: 31295416
[TBL] [Abstract][Full Text] [Related]
12. Pertussis Resurgence Associated with Pertactin-Deficient and Genetically Divergent Bordetella Pertussis Isolates in Israel.
Bamberger E; Abu Raya B; Cohen L; Golan-Shany O; Davidson S; Geffen Y; Srugo I
Pediatr Infect Dis J; 2015 Aug; 34(8):898-900. PubMed ID: 25966915
[TBL] [Abstract][Full Text] [Related]
13. Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986-2018.
Mir-Cros A; Moreno-Mingorance A; Martín-Gómez MT; Abad R; Bloise I; Campins M; González-Praetorius A; Gutiérrez MN; Martín-González H; Muñoz-Almagro C; Orellana MÁ; de Pablos M; Roca-Grande J; Rodrigo C; Rodríguez ME; Uriona S; Vidal MJ; Pumarola T; Larrosa MN; González-López JJ
Emerg Infect Dis; 2022 May; 28(5):967-976. PubMed ID: 35447067
[TBL] [Abstract][Full Text] [Related]
14. Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.
Xu Z; Octavia S; Luu LDW; Payne M; Timms V; Tay CY; Keil AD; Sintchenko V; Guiso N; Lan R
Emerg Infect Dis; 2019 Jun; 25(6):1196-1199. PubMed ID: 31107218
[TBL] [Abstract][Full Text] [Related]
15. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan.
Kodama A; Kamachi K; Horiuchi Y; Konda T; Arakawa Y
J Clin Microbiol; 2004 Dec; 42(12):5453-7. PubMed ID: 15583264
[TBL] [Abstract][Full Text] [Related]
16. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs.
Hallander HO; Advani A; Donnelly D; Gustafsson L; Carlsson RM
J Clin Microbiol; 2005 Jun; 43(6):2856-65. PubMed ID: 15956409
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.
Weber C; Boursaux-Eude C; Coralie G; Caro V; Guiso N
J Clin Microbiol; 2001 Dec; 39(12):4396-403. PubMed ID: 11724851
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial Susceptibility and Molecular Detection of Pertactin-producing and Pertactin-Deficient Bordetella pertussis.
Souder E; Vodzak J; Evangelista AT; Long SS
Pediatr Infect Dis J; 2017 Jan; 36(1):119-121. PubMed ID: 27956730
[TBL] [Abstract][Full Text] [Related]
19. Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004-2013.
Quinlan T; Musser KA; Currenti SA; Zansky SM; Halse TA
Mol Cell Probes; 2014 Aug; 28(4):138-40. PubMed ID: 24365130
[TBL] [Abstract][Full Text] [Related]
20. Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012.
Bailon H; León-Janampa N; Padilla C; Hozbor D
BMC Infect Dis; 2016 Aug; 16():422. PubMed ID: 27530444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
